Over 90% of drugs fail in clinical trials, largely due to the limited representativeness of pre-clinical models. Traditional models—whether animal or in vitro—fail to effectively capture humans' complexity and genetic diversity.

At Invitrall, we are overcoming this challenge. We develop advanced diseases in vitro models that represent human